The M&A and Healthcare teams advised Shields Health Solutions on its definitive agreement to sell the remaining 30% stake (approximately 35% on a fully-diluted basis) to Walgreens Boots Alliance, Inc. (Nasdaq: WBA) for approximately $1.37 billion, which is based on the exit multiple agreed at the time of WBA's 2021 investment in Shields.
Shields is a leader in the large, fast-growing market of specialty pharmacy, and is the premier health system-owned specialty pharmacy integrator in the United States.
Walgreens Boots Alliance is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.
The Goodwin team was led by Stuart Cable, Ed Amer, Janet Andolina, and Benjamin Gossels.
For more details, read the press release and articles in Forbes and Reuters.